Abstract：
BACKGROUND:Breast cancer incidence varies between social groups, but differences have not been thoroughly examined in New Zealand. The objectives of this study are to determine whether trends in breast cancer incidence varied by ethnicity and socioeconomic position between 1981 and 2004 in New Zealand, and to assess possible risk factor explanations. METHODS:Five cohorts of the entire New Zealand population for 1981-86, 1986-1991, 1991-1996, 1996-2001, and 2001-2004 were created, and probabilistically linked to cancer registry records, allowing direct determination of ethnic and socioeconomic trends in breast cancer incidence. RESULTS:Breast cancer rates increased across all ethnic and socioeconomic groups between 1981 and 2004. Māori women consistently had the highest age standardised rates, and the difference between Māori and European/Other women increased from 7% in 1981-6 to 24% in 2001-4. Pacific and Asian women had consistently lower rates of breast cancer than European/Other women over the time period studied (12% and 28% lower respectively when pooled over time), although young Pacific women had slightly higher incidence rates than young European/other women. A gradient between high and low income women was evident, with high income women having breast cancer rates approximately 10% higher and this difference did not change significantly over time. CONCLUSIONS:Differences in breast cancer incidence between European and Pacific women and between socioeconomic groups are explicable in terms of known risk factors. However no straightforward explanation for the relatively high incidence amongst Māori is apparent. Further research to explore high Māori breast cancer rates may contribute to reducing the burden of breast cancer amongst Māori women, as well as improving our understanding of the aetiology of breast cancer.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Cunningham R,Shaw C,Blakely T,Atkinson J,Sarfati Ddoi
10.1186/1471-2407-10-674subject
Has Abstractpub_date
2010-12-07 00:00:00pages
674issn
1471-2407pii
1471-2407-10-674journal_volume
10pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:The immune system plays an important role in the multifactorial biologic system during the development of neoplasias. However, the involvement of the inflammatory response in the promotion/control of malignant cells is still controversial, and the cell subsets and the mechanisms involved are poorly investiga...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-256
更新日期：2010-06-04 00:00:00
abstract：BACKGROUND:Tumor recurrence and metastasis are the most common reason for treatment failure. Metastasis-associate in colon cancer-1 (MACC1) has been identified as a metastatic and prognostic biomarker for colorectal cancer and other solid tumors. Aldehyde dehydrogenase 1 (ALDH1), a marker of cancer stem cells, is also ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2903-z
更新日期：2016-11-10 00:00:00
abstract：BACKGROUND:Recent large trials have shown the survival benefits of 10-year use of tamoxifen by reducing late recurrence compared with 5-year therapy in estrogen receptor(ER)-positive breast cancer. We tried to identify clinical factors associated with the late recurrence. METHODS:We reviewed our database of ER-positiv...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2423-x
更新日期：2016-07-07 00:00:00
abstract：BACKGROUND:Androgen deprivation therapy (ADT) is a cornerstone in the treatment of advanced prostate cancer. Adverse musculoskeletal and cardiovascular effects of ADT are widely reported and investigations into the potential of exercise to ameliorate the effects of treatment are warranted. The 'Football Club (FC) Prost...
journal_title：BMC cancer
pub_type： 杂志文章,随机对照试验
doi：10.1186/1471-2407-13-595
更新日期：2013-12-13 00:00:00
abstract：BACKGROUND:Papillary renal cell carcinoma (pRCC) is the 2nd most frequent histological type of kidney cancer and accounts for approximately 15% of all renal cell carcinoma. It has a poorer prognosis than clear cell RCC (ccRCC) with a lack of standard treatments. CASE PRESENTATION:We report the case of a 51 year old ma...
journal_title：BMC cancer
pub_type： 杂志文章,评审
doi：10.1186/s12885-018-5049-3
更新日期：2018-11-22 00:00:00
abstract：BACKGROUND:Breast cancer is the leading cause of cancer morbidity among Shanghai and Hong Kong women, which contributes to 20-25% of new female cancer incidents. This study aimed to describe the temporal trend of breast cancer and interpret the potential effects on the observed secular trends. METHODS:Cancer incident ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3359-5
更新日期：2017-05-23 00:00:00
abstract：BACKGROUND:Crosstalk between malignant hepatocytes and the surrounding peritumoral stroma is a key modulator of hepatocarcinogenesis and therapeutic resistance. To examine the chemotherapy resistance of these two cellular compartments in vitro, we evaluated a well-established hepatic tumor cell line, HepG2, and an adul...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-402
更新日期：2012-09-10 00:00:00
abstract：BACKGROUND:The objectives of this study were to build a normal tissue complication probability (NTCP) model of radiation-induced hypothyroidism (RHT) for nasopharyngeal carcinoma (NPC) patients and to compare it with other four published NTCP models to evaluate its efficacy. METHODS:Medical notes of 174 NPC patients a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4348-z
更新日期：2018-05-18 00:00:00
abstract：BACKGROUND:Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is a benign lymphoid proliferation or malignant lymphoma in patients who have been treated with MTX. MTX withdrawal and observation for a short period should be considered in the initial management of patients who develop LPD while on MTX therapy...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2672-8
更新日期：2016-08-15 00:00:00
abstract：BACKGROUND:We examined 15 years of key performance indicators (KPIs) of the population-based mammography screening programme (PMSP) in Flanders, Belgium. METHODS:Individual screening data were linked to the national cancer registry to obtain oncological follow-up. We benchmarked crude KPI results against KPI-targets s...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6230-z
更新日期：2019-10-28 00:00:00
abstract：BACKGROUND:Evasion of immune surveillance and suppression of the immune system are important hallmarks of tumorigenesis. The goal of this study was to establish distinct patterns that reflect a rectal tumors' immune-phenotype and to determine their relation to patient outcome. METHODS:The study population consisted of...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-486
更新日期：2014-07-05 00:00:00
abstract：BACKGROUND:Mammalian target of rapamycin (mTOR) inhibitors have anti-tumor effects against renal cell carcinoma, pancreatic neuroendocrine cancer and breast cancer. In this study, we analyzed the antitumor effects of mTOR inhibitors in small cell lung cancer (SCLC) cells and sought to clarify the mechanism of resistanc...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1202-4
更新日期：2015-04-09 00:00:00
abstract：BACKGROUND:Modeling the relationship between age and mortality for breast cancer patients may have important prognostic and therapeutic implications. METHODS:Data from 9 registries of the Surveillance, Epidemiology, and End Results Program (SEER) of the United States were used. This study employed proportional hazards...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-5-130
更新日期：2005-10-08 00:00:00
abstract：BACKGROUND:Interpretation of comparative health-related quality of life (HRQOL) studies following different prostate cancer treatments is often difficult due to differing patient ages. Furthermore, age-related changes can hardly be discriminated from therapy-related changes. The evaluation of age-and comorbidity-relate...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-296
更新日期：2009-08-24 00:00:00
abstract：BACKGROUND:Breast cancer mortality steadily declined from the 1990s and this has been attributed to early detection and/or to improvements in therapy. Which of those two has had the greater impact is a subject of contention. METHODS:A database of 386 patients, enrolled in a randomized clinical trial on the effect of a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-702
更新日期：2014-09-24 00:00:00
abstract：BACKGROUND:Since most glioblastomas express both wild-type EGFR and EGFRvIII as well as HER2/neu, they are excellent targets for activated T cells (ATC) armed with bispecific antibodies (BiAbs) that target EGFR and HER2. METHODS:ATC were generated from PBMC activated for 14 days with anti-CD3 monoclonal antibody in th...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-83
更新日期：2013-02-22 00:00:00
abstract：BACKGROUND:Cancer is a major public health issue and represents a significant economic burden to health care systems worldwide. The objective of this analysis was to estimate phase-specific, 5-year and lifetime net costs for the 21 most prevalent cancer sites, and remaining tumour sites combined, in Ontario, Canada. M...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2835-7
更新日期：2016-10-18 00:00:00
abstract：BACKGROUND:CRC is one of the most common malignancies worldwide, and its molecular mechanisms remain unclear. Elevated levels of BAG3 have been reported in various tumors. The present study aimed to explore the expression and function of BAG3 in CRC. METHODS:BAG3 protein expression was evaluated in 90 CRC specimens us...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4657-2
更新日期：2018-08-06 00:00:00
abstract：BACKGROUND:The receptor tyrosine kinases (RTKs) play critical roles in the development of cancers. Clear cell renal cell carcinoma (ccRCC) accounts for 75% of the RCC. The previous studies on the RTKs in ccRCCs mainly focused on their gene expressions. The activation and function of the RTKs in ccRCC have not been full...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6159-2
更新日期：2019-11-05 00:00:00
abstract：BACKGROUND:Renal cell carcinoma (RCC) is a seventh ranked malignancy with poor prognosis. RCC is lethal at metastatic stage as it does not respond to conventional systemic treatments, and there is an urgent need to find out promising novel biomarkers for effective treatment. The goal of this study was to evaluate the b...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2775-2
更新日期：2016-09-30 00:00:00
abstract：BACKGROUND:Cancers of unknown primary origin (CUPs) are reported to be the 3-4th most common causes of cancer death. Recent years have seen advances in mutational analysis and genomics profiling. These advances could improve accuracy of diagnosis of CUPs and might improve the prognosis of patients with CUPs. CASE PRES...
journal_title：BMC cancer
pub_type： 杂志文章,评审
doi：10.1186/s12885-019-5277-1
更新日期：2019-01-11 00:00:00
abstract：BACKGROUND:The radiopharmaceutical (131)I-meta-iodobenzylguanidine ((131)I-MIBG) is an effective treatment for neuroblastoma. However, maximal therapeutic benefit from (131)I-MIBG is likely to be obtained by its combination with chemotherapy. We previously reported enhanced antitumour efficacy of (131)I-MIBG by inhibit...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2656-8
更新日期：2016-08-11 00:00:00
abstract：BACKGROUND:As inadequate pain communication contributes to difficulties in optimizing outcomes of outpatients, we investigated the effect of reinforced education using WeChat App to the opioid titration treatment of cancer-related pain in the outpatient setting. METHODS:We conducted a prospective study to compare rein...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07270-w
更新日期：2020-09-04 00:00:00
abstract：BACKGROUND:MicroRNAs (miRNAs) are short, non-coding RNAs (~22 nt) that play important roles in the pathogenesis of human diseases by negatively regulating gene expression. Although miR-196a has been implicated in several other cancers, its role in non-small cell lung cancer (NSCLC) is unknown. The aim of the present st...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-348
更新日期：2012-08-09 00:00:00
abstract：BACKGROUND:Reliable methods are needed to identify patients with early-stage cancer or high-grade precancerous lesions in the pancreas. Analysis of pancreatic juice to detect somatic mutations could represent one such approach. Here we investigated the concordance between mutations found in the primary tumor and pancre...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-5195-7
更新日期：2019-01-05 00:00:00
abstract：BACKGROUND:The literature on sexual orientation disclosure is arguably one of the most developed in the field of lesbian, gay and bisexual (LGB) people in healthcare in English speaking countries however, relatively little research has been conducted into disclosure in cancer care. Studies have been mainly undertaken i...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5895-7
更新日期：2019-07-10 00:00:00
abstract：BACKGROUND:We evaluated the hierarchical risk groups for the estimated survival of WHO grade III glioma patients using recursive partitioning analysis (RPA). To our knowledge, this is the first study to address the results of RPA specifically for WHO grade III gliomas. METHODS:A total of 133 patients with anaplastic a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-450
更新日期：2009-12-18 00:00:00
abstract：BACKGROUND:Although advanced-stage cervical cancer can benefit from current treatments, approximately 30% patients may fail after definitive treatment eventually. Therefore, exploring alternative molecular therapeutic approaches is imperatively needed for this disease. We have recently shown that activation of AMP-acti...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-327
更新日期：2013-07-03 00:00:00
abstract：BACKGROUND:Acute myeloid leukemia (AML) is predominantly a disease of older patients with a poor long-term survival. Approval of decitabine (DAC) in the European Union (EU) in 2012 for the treatment of patients with AML ≥65 years marks the potential for hypomethylating agents in elderly AML. Nevertheless the situation ...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1186/s12885-015-1432-5
更新日期：2015-05-26 00:00:00
abstract：BACKGROUND:Spinal bone metastases are commonly diagnosed in cancer patients. The consequences are pain both at rest and under exercise, impairment of activities of daily life (ADL), reduced clinical performance, the risk of pathological fractures, and neurological deficits. The aim of this randomized, controlled pilot ...
journal_title：BMC cancer
pub_type： 杂志文章,随机对照试验
doi：10.1186/1471-2407-14-67
更新日期：2014-02-05 00:00:00
